Literature DB >> 12517947

Nonmyelin-specific T cells accelerate development of central nervous system APC and increase susceptibility to experimental autoimmune encephalomyelitis.

Richard E Jones1, Thomas Kay, Thomas Keller, Dennis Bourdette.   

Abstract

Previously we demonstrated that both myelin-specific and nonmyelin-specific rat T cells were capable of accelerating the development of transplanted rat BM-derived APC in the CNS of SCID C.B-17/scid (SCID) mice. This suggested that nonmyelin-specific T cells might be capable of increasing susceptibility to EAE by increasing the number and function of APC in the CNS before disease induction. To assess this possibility, we evaluated disease incidence, day of onset, duration, mean peak severity, cumulative disease index, and histopathology in the presence or absence of nonmyelin-specific T cells. The results demonstrate an association between T cell responses to nonmyelin Ags, accelerated development of BM-derived CNS APC before disease induction, and heightened susceptibility to CNS inflammation mediated by myelin-specific T cells. This suggests that T cell responses to nonmyelin Ags can potentiate CNS inflammation by elevating the functional presence of CNS APC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517947     DOI: 10.4049/jimmunol.170.2.831

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  TGF-β signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE.

Authors:  David J Huss; Ryan C Winger; Gina Mavrikis Cox; Mireia Guerau-de-Arellano; Yuhong Yang; Michael K Racke; Amy E Lovett-Racke
Journal:  Eur J Immunol       Date:  2011-08-30       Impact factor: 5.532

Review 2.  Emerging role of bystander T cell activation in autoimmune diseases.

Authors:  Chae-Hyeon Shim; Sookyung Cho; Young-Mi Shin; Je-Min Choi
Journal:  BMB Rep       Date:  2022-02       Impact factor: 4.778

Review 3.  Bystander CD4+ T cells: crossroads between innate and adaptive immunity.

Authors:  Hong-Gyun Lee; Min-Zi Cho; Je-Min Choi
Journal:  Exp Mol Med       Date:  2020-08-28       Impact factor: 8.718

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.